Yang, Victor http://orcid.org/0000-0003-0013-9865
Kragstrup, Tue W. http://orcid.org/0000-0002-6439-397X
McMaster, Christopher http://orcid.org/0000-0003-2432-5451
Reid, Pankti http://orcid.org/0000-0002-7645-0919
Singh, Namrata http://orcid.org/0000-0001-7149-363X
Haysen, Stine R. http://orcid.org/0009-0006-7489-5339
Robinson, Philip C. http://orcid.org/0000-0002-3156-3418
Liew, David F. L. http://orcid.org/0000-0001-8451-8883
Funding for this research was provided by:
University of Melbourne
Article History
Accepted: 20 June 2023
First Online: 25 July 2023
Declarations
:
: Open Access funding enabled and organized by CAUL and its Member Institutions.
: TWK declares speaking fees from Pfizer, Bristol-Myers Squibb, Eli Lilly, Novartis, UCB, and Abbvie; consultancy fees from Bristol-Myers Squibb, UCB, Gilead, and Eli-Lilly; and research grants from Gilead, and is co-founder and clinical developer in Aptol Pharma. PR declares support from the University of Chicago Institute of Translational Medicine Clinical and Translational Science Award K12/KL2 grant 5KL2TR002387-05 and COVID-19 Funds to Retain Clinical Scientists by the SECURED (Supporting Early Career University Researchers to Excel through Disruptions) Steering Committee. NS declares support from the National Institute Of Arthritis And Musculoskeletal And Skin Diseases of the National Institutes of Health under award no. K23AR079588. PCR declares personal fees from Abbvie, Atom Biosciences, Eli Lilly, Gilead, GlaxoSmithKline, Janssen, Kukdong, Novartis, UCB, Roche, and Pfizer; meeting attendance support from Bristol Myers Squibb, Roche, Pfizer, and UCB; and grant funding from Janssen, Novartis, Pfizer, and UCB. DFLL declares membership in the Drug Utilisation Subcommittee of the Pharmaceutical Benefits Advisory Committee, Australian Government. VY, CM, and SRH declare no competing interests.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: DFLL and PCR conceptualized the structure of the review. VY, DFLL, TWK, CM, PR, NS, and SRH drafted and revised the paper. All authors read and approved the final version.